Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.1008
-0.0057 (-5.35%)
Mar 16, 2026, 1:55 PM EDT - Market open
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $5.61 million as of March 16, 2026. Its market cap has decreased by -90.82% in one year.
Market Cap
5.61M
Enterprise Value
-2.67M
1-Year Change
-90.82%
Ranking
Category
Stock Price
$0.10
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $5.61M, a decrease of -99.34%. That is a compound annual growth rate of -52.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 5.93M | -96.82% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 6.68M |
| Moleculin Biotech | 6.53M |
| BioRestorative Therapies | 6.49M |
| Xenetic Biosciences | 6.43M |
| Immuron | 6.39M |
| Liminatus Pharma | 6.31M |
| Cyclerion Therapeutics | 5.69M |
| Psyence Biomedical | 5.64M |